Item 1.01. Entry into a Material Definitive Agreement.
Merger Agreement
Plantronics, Inc. (the “Company”) entered into an Agreement and Plan of Merger dated as of March 25, 2022 (the “Merger Agreement”) with HP Inc. (“Parent”) and Prism Subsidiary Corp. (“Merger Sub”), a wholly owned
subsidiary of Parent. The Merger Agreement provides that, on the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a
wholly owned subsidiary of Parent.
The Company’s Board of Directors (the “Company Board”) determined that the transactions contemplated by the Merger Agreement, including the Merger, are in the best interests of the Company and its stockholders, and
approved the Merger Agreement and the transactions contemplated by the Merger Agreement. The Company Board also resolved to recommend that the Company’s stockholders vote to adopt and approve the Merger Agreement and the Merger.
Under the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock of the Company (the “Company Common Stock”), subject to certain exceptions set forth in the Merger
Agreement, will be canceled and extinguished and will be converted into the right to receive $40.00 in cash, without interest (the “Per Share Price”).
At or immediately prior to the effective time of the Merger, the Company’s stock options will be treated in the following manner:
|
• |
Each vested and unvested outstanding stock option of the Company that has an exercise price per share less than the Per Share Price will be canceled and converted into the right to receive an amount in cash equal to the Per Share Price (less the exercise price per share for such stock option) multiplied by the number of shares of Company Common Stock issuable upon exercise in full of such stock option.
|
|
• |
Each vested and unvested outstanding stock option of the Company that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled without payment.
|
At or immediately prior to the effective time of the Merger, the Company’s equity-based awards will be treated in the following manner:
|
• |
Each outstanding share of restricted stock of the Company will vest in full and be converted into the right to receive the Per Share Price.
|
|
• |
Each outstanding restricted stock unit of the Company (a “Company RSU”) that was granted prior to the date of the Merger Agreement will be canceled and converted into the right to receive an amount in cash equal to the Per Share Price multiplied by the number of shares of the Company Common Stock subject to such Company RSU.
|
|
• |
Each outstanding Company RSU that is subject to performance-based vesting conditions (a “Company PSU”) that was granted prior to the date of the Merger Agreement will be canceled and converted into the right to receive an amount in cash
equal to the Per Share Price multiplied by the total number of shares of Company Common Stock subject to such Company PSU; the Leadership Development and Compensation Committee of the Company Board
will calculate the number of Company PSUs that vest in connection with the Merger in accordance with the terms of the applicable Company stock plan and award agreement governing such Company PSU.
|
|
• |
Each outstanding Company RSU that was granted on or after the date of the Merger Agreement (a “Company Interim RSU”) will be either (in the sole discretion of Parent) (i) assumed by Parent and converted into restricted stock units of
Parent (each, an “Assumed RSU”) with respect to a number of shares of common stock of Parent (the “Parent Common Stock”) that is equal to the number of shares of Company Common Stock subject to such Company Interim RSU multiplied by (a) the
Per Share Price divided by (b) the average closing price per share of Parent Common Stock on the NYSE for the ten trading-day period ending on the trading day preceding the date of the closing of the Merger, and such Assumed RSU will be
subject to the vesting schedule that is applicable to such Company Interim RSU and the other terms and conditions applicable to such Company Interim RSU as in effect immediately prior to the closing of the Merger; or (ii) canceled and
converted into the right to receive an amount in cash equal to the total number of shares of Company Common Stock subject to such Company Interim RSU immediately prior to the closing of the Merger, multiplied by the Per Share Price, with
such amount payable on the vesting schedule that is applicable to such Company Interim RSU as in effect immediately prior to the closing of the Merger and otherwise subject to the other terms and conditions applicable to such Company
Interim RSU as in effect immediately prior to the closing of the Merger.
|
|
• |
Each outstanding Company PSU that was granted on or after the date of the Merger Agreement (a “Company Interim PSU”) will be canceled and exchanged for a Company Interim RSU with respect to a number of shares of Company Common Stock
equal to the number of shares of the Company Common Stock subject to such Company Interim PSU with respect to target performance (on a one-for-one basis), and with the same remaining time-based vesting schedule (annual ratable vesting over
three years) that would have been applicable had the Company Interim PSU been initially granted as a Company Interim RSU, and such award will be treated as a Company Interim RSU as described above.
|
Under the Merger Agreement, consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions, including, among others: (i) adoption and approval of the Merger Agreement by the
Company’s stockholders by the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock; (ii) the absence of any legal restraint by a court or
governmental authority of competent jurisdiction preventing, prohibiting or making illegal the consummation of the Merger; and (iii) the expiration or termination of the waiting period under the
United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and clearance under the antitrust and foreign investment laws of certain non-United States jurisdictions. Parent’s consummation of financing arrangements required to
complete the Merger, if any, is not a condition to the consummation of the Merger.
The Merger Agreement contains customary representations, warranties and covenants made by each of the Company, Parent and Merger Sub, including, among others, covenants by the Company
regarding the conduct of its business prior to the closing of the Merger. Beginning on the date of the Merger Agreement, the Company is subject to customary ”no-shop” restrictions pursuant to which the Company
is required, among other things, not to solicit, initiate, knowingly encourage or knowingly facilitate any Takeover Proposals (as defined in the Merger Agreement) and, subject to certain exceptions, not to engage in discussions or negotiations
regarding, or furnish to any person any non-public information with respect to, any such Takeover Proposal. In addition, the Company has agreed that, subject to certain exceptions, the Company Board will not
change, modify or withdraw its recommendation that the Company’s stockholders vote to adopt and approve the Merger Agreement. The Company has also agreed that, unless the Merger Agreement is validly
terminated, the Company will file with the Securities and Exchange Commission (the “SEC”) a proxy statement in preliminary form relating to the adoption of the Merger Agreement by the Company’s stockholders no later than the 25th business day after the date of the Merger Agreement, and the Company will convene and hold a special meeting of the Company’s stockholders for the purpose of seeking
the adoption of the Merger Agreement by the Company’s stockholders no later than the 40th calendar day after the mailing of the definitive proxy statement has
commenced.
Either the Company or Parent may terminate the Merger Agreement if, among certain other circumstances, (i) the Merger has not been consummated on or before December 27, 2022, which date may
be extended automatically for two successive 90 day extensions in certain circumstances where the Merger has not been consummated because of the failure to obtain clearance, or the imposition of legal restraints, under
antitrust and foreign investment laws or (ii) the Company’s stockholders fail to adopt and approve the Merger Agreement. The Company may terminate the Merger Agreement in certain additional circumstances, including to allow the Company to enter
into a definitive agreement for an alternative acquisition proposal that constitutes a Superior Proposal (as defined in the Merger Agreement). Parent may terminate the Merger Agreement in certain additional limited circumstances, including if the
Company Board withdraws its recommendation that the Company’s stockholders vote to adopt and approve the Merger Agreement, or if the Company’s “no shop” restrictions are breached in any material respect.
Upon termination of the Merger Agreement under the limited specified circumstances, the Company will be required to pay Parent a termination fee of $66,000,000. Specifically, this termination fee is payable by the
Company to Parent if the Merger Agreement is terminated by (i) Parent because the Company Board withdraws its recommendation that the Company’s stockholders vote to adopt and approve the Merger Agreement and
the Merger; (ii) Parent because the Company’s “no shop” restrictions are breached in any material respect; or (iii) the Company to enter into a definitive agreement for a Superior Proposal. The termination fee
will also be payable if the Merger Agreement is terminated in certain circumstances after a proposal for, generally speaking, a Takeover Proposal with respect to at least 50 percent of the Company’s stock or assets has been made to the Company or
to the Company’s stockholders generally or has otherwise become publicly known, and the Company subsequently enters into a definitive agreement providing for, or consummates, an alternative transaction with respect to at least 50 percent of the
Company’s stock or assets within one year after termination.
The Merger Agreement also provides that the Company, on one hand, or Parent and Merger Sub, on the other hand, may specifically enforce the obligations under the Merger Agreement.
The foregoing description of the Merger Agreement is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed as Exhibit 2.1 and is incorporated into
this report by reference.
The Merger Agreement contains representations and warranties by each of Parent, Merger Sub and the Company. These representations and warranties were made solely for the benefit of the parties to the
Merger Agreement and:
|
• |
should not be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
• |
may have been qualified in the Merger Agreement by disclosures that were made to the other party in connection with the negotiation of the Merger Agreement;
|
|
• |
may apply contractual standards of “materiality” that are different from “materiality” under applicable securities laws; and
|
|
• |
were made only as of the date of the Merger Agreement or such other date or dates as may be specified in the Merger Agreement.
|
Additional Information and Where to Find It
The Company, its directors and certain executive officers are participants in the solicitation of proxies from stockholders in connection with the proposed acquisition of the
Company (the “Transaction”). The Company plans to file a proxy statement (the “Transaction Proxy Statement”) with the SEC in connection with the solicitation of proxies to approve the Transaction. Robert C. Hagerty, Marv Tseu, Kathy Crusco, Brian
Dexheimer, Greggory Hammann, Guido Jouret, Talvis Love, Marshall Mohr, Daniel Moloney, David Shull and Yael Zheng, all of whom are members of the Company Board, and Charles Boynton who is the Company’s Executive Vice President and Chief Financial
Officer, are participants in the Company’s solicitation. None of such participants owns individually in excess of 1% of the Company Common Stock. Additional information regarding such participants, including their direct or indirect interests, by
security holdings or otherwise, will be included in the Transaction Proxy Statement and other relevant documents to be filed with the SEC in connection with the Transaction. Information relating to the foregoing can also be found in the Company’s
definitive proxy statement for its 2021 Annual Meeting of Stockholders (the “2021 Proxy Statement”), which was filed with the SEC on June 14, 2021. To the extent that holdings of the Company’s securities have changed since the amounts printed in
the 2021 Proxy Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC.
Promptly after filing the definitive Transaction Proxy Statement with the SEC, the Company will mail the definitive Transaction Proxy Statement and a WHITE proxy card to each
stockholder entitled to vote at the special meeting to consider the Transaction. STOCKHOLDERS ARE URGED TO READ THE TRANSACTION PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL
FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain, free of charge, the preliminary and definitive versions of the Transaction Proxy Statement, any amendments or supplements
thereto, and any other relevant documents filed by the Company with the SEC in connection with the Transaction at the SEC’s website (http://www.sec.gov). Copies of the Company’s definitive Transaction Proxy Statement, any amendments or supplements
thereto, and any other relevant documents filed by the Company with the SEC in connection with the Transaction will also be available, free of charge, at the Company’s investor relations website (https://investor.poly.com) or by contacting the
Company’s Investor Relations at IR@poly.com.
Forward-Looking Statements
This communication contains forward-looking statements that involve risks and uncertainties, including statements regarding: the Transaction, including the expected timing of the
closing of the Transaction; the anticipated benefits of the Transaction and other considerations taken into account by the Company Board in approving the Transaction; and expectations for the Company prior to and following the closing of the
Transaction. If any of these risks or uncertainties materialize, or if any of the Company’s assumptions prove incorrect, the Company’s actual results could differ materially from the results expressed or implied by these forward-looking statements.
Additional risks and uncertainties include those associated with: the possibility that the conditions to the closing of the Transaction are not satisfied on a timely basis or at all, including the risk that the required approval from the Company’s
stockholders for the Transaction or required regulatory approvals to consummate the Transaction are not obtained; potential litigation relating to the Transaction; uncertainties as to the timing of the consummation of the Transaction; the ability
of each party to consummate the Transaction; the occurrence of any event, change or other circumstances that could give rise to the right to terminate the Transaction; possible disruption related to the Transaction to the Company’s current plans
and operations, including through the loss of employees, customers and business partners; economic, market, business or geopolitical conditions (including resulting from the COVID-19 pandemic, supply chain disruptions, or the military conflict in
Ukraine and related sanctions against Russia and Belarus) or competition, or changes in such conditions, negatively affecting the Company’s business, operations and financial performance; the failure to realize anticipated benefits of the
Transaction when expected or at all; and other risks and uncertainties detailed in the periodic reports that the Company files with the SEC, including the Company’s Annual Report on Form 10-K filed with the SEC on May 18, 2021, and Quarterly
Reports on Form 10-Q filed with the SEC on July 30, 2021, October 28, 2021 and February 8, 2022, each of which may be obtained on the investor relations section of the Company’s website (https://investor.poly.com). All forward-looking statements in
this communication are based on information available to the Company as of the date of this communication, and the Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were made, except as required by law.